Medicare Enrolled

Marina Lebrun

Nurse Practitioner - Adult Health · Hollywood, FL
3850 HOLLYWOOD BLVD, Hollywood, FL 33021
9548749170
Registered in NPPES since 2019
NPI: 1851856439 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Lebrun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Lebrun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Lebrun

Marina Lebrun is a nurse practitioner - adult health in Hollywood, FL, with 7 years of NPI registration.

Between the years covered by Open Payments, Lebrun received a total of $6,840 from 54 pharmaceutical and/or device companies across 247 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Lebrun is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years of NPI registration $6,840 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Advanced Practice Registered Nurse 11000594 Clear Expired July 31, 2026
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗
$6,840
Total received (2021-2024)
Avg $2,280/year across 3 years
Top 5% in FL for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
247
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,650
2023
$2,053
2021
$137

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$1,192
PFIZER INC.
$367
Merck Sharp & Dohme LLC
$295
Coherus Biosciences Inc.
$240
SEAGEN INC.
$195
Daiichi Sankyo Inc.
$193
Janssen Biotech, Inc.
$159
Lilly USA, LLC
$144
AstraZeneca Pharmaceuticals LP
$129
Incyte Corporation
$125
JAZZ PHARMACEUTICALS INC.
$108
Genentech USA, Inc.
$96
TAIHO ONCOLOGY, INC.
$92
GlaxoSmithKline, LLC.
$74
PharmaEssentia USA Corporation
$72
Bayer Healthcare Pharmaceuticals Inc.
$71
ARRAY BIOPHARMA INC
$68
Mirati Therapeutics, Inc.
$60
Eisai Inc.
$58
TerSera Therapeutics LLC
$56
ABBVIE INC.
$55
BeiGene USA, Inc.
$54
Deciphera Pharmaceuticals Inc.
$53
Tempus AI, Inc
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
SERVIER PHARMACEUTICALS LLC
$49
Ipsen Biopharmaceuticals, Inc
$47
EMD Serono, Inc.
$44
Exelixis Inc.
$40
Stemline Therapeutics Inc.
$38
Napo Pharmaceuticals Inc
$35
Pharmacosmos Therapeutics Inc.
$34
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Adaptive Biotechnologies Corporation
$30
Myriad Genetic Laboratories, Inc.
$28
Aveo Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$26
Astellas Pharma US Inc
$25
Biocon Biologics Inc
$24
Blue Earth Diagnostics Limited
$23
Genmab U.S., Inc.
$22
SOBI, INC
$20
GENZYME CORPORATION
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 39.9% of 2024 payments
All-time payments by company (2021-2024) ›
Novartis Pharmaceuticals Corporation
$1,422
PFIZER INC.
$545
Merck Sharp & Dohme LLC
$445
Janssen Biotech, Inc.
$381
Lilly USA, LLC
$244
Coherus Biosciences Inc.
$240
Daiichi Sankyo Inc.
$217
Myriad Genetic Laboratories, Inc.
$207
SEAGEN INC.
$195
Genentech USA, Inc.
$192
Incyte Corporation
$191
Takeda Pharmaceuticals U.S.A., Inc.
$191
AstraZeneca Pharmaceuticals LP
$182
PharmaEssentia USA Corporation
$147
JAZZ PHARMACEUTICALS INC.
$137
TerSera Therapeutics LLC
$135
TAIHO ONCOLOGY, INC.
$134
Bayer Healthcare Pharmaceuticals Inc.
$100
GlaxoSmithKline, LLC.
$95
Mirati Therapeutics, Inc.
$92
ARRAY BIOPHARMA INC
$90
ABBVIE INC.
$78
SERVIER PHARMACEUTICALS LLC
$71
Pharmacosmos Therapeutics Inc.
$70
EMD Serono, Inc.
$64
Exelixis Inc.
$58
Eisai Inc.
$58
Stemline Therapeutics Inc.
$57
BeiGene USA, Inc.
$54
Deciphera Pharmaceuticals Inc.
$53
Tempus AI, Inc
$53
Blue Earth Diagnostics Limited
$51
Adaptive Biotechnologies Corporation
$51
Astellas Pharma US Inc
$50
Ipsen Biopharmaceuticals, Inc
$47
Amneal Pharmaceuticals LLC
$44
Kite Pharma, Inc.
$38
Napo Pharmaceuticals Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Aveo Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$26
Celgene Corporation
$24
Biocon Biologics Inc
$24
ImmunoGen, Inc.
$24
Genmab U.S., Inc.
$22
Seagen Inc.
$22
ADC Therapeutics America, Inc.
$21
SOBI, INC
$20
GENZYME CORPORATION
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
Sirtex Medical Inc
$15
Amgen Inc.
$13
NOVARTIS PHARMACEUTICALS CORPORATION
$13
Janssen Pharmaceuticals, Inc
$10
Top 3 companies account for 35.3% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AVASTIN · Alecensa · Axumin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CERDELGA · DARZALEX · DOPTELET · ELAHERE · ELIQUIS · ELREXFIO · ERLEADA · Elahere · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · Fabhalta · Fulphila · GELCLAIR CONCENTRATED ORAL GEL · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LONSURF · LORBRENA · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MONOFERRIC · MYRISK · NINLARO · Nubeqa · OJJAARA · Odomzo · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POSLUMA · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · Quzyttir · RYBREVANT · SIR-Spheres Microspheres · TECVAYLI · TIVDAK · Tecentriq · Tibsovo · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vyloy · XOSPATA · XT CDX · XTANDI · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Hollywood?
Compare adult-health nurse practitioners in the Hollywood area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
554
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
MEMORIAL REGIONAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Lebrun is a nurse practitioner - adult health.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Lebrun receive payments from pharmaceutical companies?
Yes. Lebrun received a total of $6,840 from 54 companies across 247 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Lebrun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →